Wang, Z., Lu, Y., Han, M., Li, A., Ruan, M., Tong, Y., . . . Chen, X. (2024). Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer. Breast Cancer Research and Treatment, 208(2), 429-440. https://doi.org/10.1007/s10549-024-07436-1
Chicago Style (17th ed.) CitationWang, Zheng, et al. "Association Between Homologous Recombination Deficiency Status and Carboplatin Treatment Response in Early Triple-negative Breast Cancer." Breast Cancer Research and Treatment 208, no. 2 (2024): 429-440. https://doi.org/10.1007/s10549-024-07436-1.
MLA (9th ed.) CitationWang, Zheng, et al. "Association Between Homologous Recombination Deficiency Status and Carboplatin Treatment Response in Early Triple-negative Breast Cancer." Breast Cancer Research and Treatment, vol. 208, no. 2, 2024, pp. 429-440, https://doi.org/10.1007/s10549-024-07436-1.